LWBP

SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO., LTD., located in Minxin High-Tech Park, Shanghai, is a research and development-oriented high-tech enterprise dedicated to the R&D and industrialization of proprietary active pharmaceutical ingredients (APIs) and formulations, as well as the research and development of Class I new drugs. The founding team, led by the company's founder who is a national specially appointed expert under the National Thousand Talents Plan, has decades of working experience in the U.S. and has achieved numerous internationally influential accomplishments, including hundreds of published invention patents and papers, as well as several drugs at various clinical stages or already on the market. The company has made significant breakthroughs in proprietary R&D, owning multiple invention patents in APIs and drug fields. It has also established extensive and in-depth collaborations with many well-known enterprises both domestically and internationally, focusing on major projects such as hepatitis B, cancer, and cardiovascular diseases.